Ionis Pharmaceuticals, Inc. · NASDAQ:IONS

Jenne Kyle sold 4,902 Ionis Pharmaceuticals, Inc. shares (Form 4)

Traded Apr 15 to Apr 16, 2026 · Filed Apr 17, 2026

From Apr 15 to Apr 16, 2026, Jenne Kyle (EVP, Chf GL Pdt Str Ofcr) sold 4,902 Ionis Pharmaceuticals, Inc. shares at US$75.17 for US$368K, leaving 23,713 shares. Filed Apr 17, 2026 (Form 4).

Sold
4,902 shares
Price
US$75.17
Value
US$368K
Holding after
23,713 shares
Trading plan
No
Role
EVP, Chf GL Pdt Str Ofcr

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockOption exercise12,22628,615Direct
Apr 16, 2026Common StockSale4,902US$75.1723,713Direct

Source

View original at SEC

Related